Allakos Inc
Biotechnology
Healthcare
ALLK
86.65 M shares
NASDAQ US
traded
02 Jan 2024
listed
no
open
2.74
52 week high
8.42
high
2.80
52 week low
1.72
low
2.67
growth
-65.40 %
previous Close
2.73
P/E ratio
market cap
366 M
div yield
0
usd
Jun 2023
qoq
revenue
0.00 %
net incoming
-35.12 M
17.18 %
eps
0.00 %
16.33 %
eps surprise
14.58 %
net profit margin
-3512000000.00 %
0.00 %
operating incoming
-37.82 M
16.05 %
net change in cash
-26.47 M
-498.87 %
cash on hand
67.38 M
-28.21 %
cost of revenue
0.00 %
top top